Investor Presentaiton
Since the launch of the Opioid
Action Plan, we've advanced many
strategies:
Received over $54 million in federal funding which provided
treatment for over 12,000 people.
Increased the number of Syringe Exchange Programs, and served
over 5,000 people annually through them.
Trained over 3,000 providers on clinical issues related to the
epidemic, include safe prescribing of opioids and pain treatment.
Funded peer support specialists with lived experience in emergency
departments to connect people with substance use disorders (SUDS)
to ongoing services and supports.
ā Launched a medical residency training project that will give over 400
prescribers their DATA 2000 waiver to prescribe buprenorphine, and
work with over 20 residency programs to incorporate the DATA 2000
waiver into their curriculum ongoing.View entire presentation